PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026The International Journal of Neuropsychopharmacology1 citationsOpen Access

Identification of antidepressant response-related changes to DNA methylation and gene expression

View Full Paper
LFLaura FioriCNCorina NagyGTGustavo Turecki

Key Points

  • Antidepressant treatment response correlates with changes in DNA methylation and gene expression.
  • We identified 10 specific methylation sites linked to clinical improvement in depression, affecting treatment outcomes.
  • Analysis of blood samples revealed significant changes in gene expression alongside DNA methylation alterations.
  • These findings highlight potential biomarkers for predicting response to antidepressants, guiding future therapies.

Abstract

Antidepressant treatment response is associated with changes in peripheral DNA methylation over time, as well as corresponding alterations in gene expression. Significance Statement Major depressive disorder (MDD) is commonly treated with antidepressants; however, many people do not respond to treatment. In order to better understand the molecular changes that occur during antidepressant treatment, we analyzed DNA methylation and gene expression in the blood of 154 individuals with MDD who were treated with escitalopram or desvenlafaxine. We found 10 methylation sites within 10 genes whose methylation levels changed over time in relation to clinical improvement, and whose levels of expression were related to both methylation and antidepressant response.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fiori et al. (2026) studied this question.

synapsesocial.com/papers/69a75c61c6e9836116a25378https://doi.org/10.1093/ijnp/pyag001
Ask AI
Helpful
Bookmark
Share
View Full Paper